Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- NCNO +23.4% (also authorizes $100 mln accelerated share repurchase program), TH +19.9% (lands $550 mln data center contract, raises outlook), SHAZ +15.1%, PLAY +5.6%, OMER +4.6%, CALM +3.6%, TLRY +3.6%, ARES +1.7% (lower Q1 guidance, also raises over $9.8 bln for leading opportunistic credit strategy), RILY +1.6%, PVH +1.5%, ASTL +1%
Other news:
- NERV +5.9% (first patient screened in Phase 3 confirmatory trial)
- IMUX +5.2% (regains Nasdaq compliance after meeting minimum bid requirement)
- GALT +4.7% (files for $200 mln mixed securities shelf offering)
- LI +4.6% (March deliveries)
- KBDC +4.5% (entered into $150 mln equity distribution agreements)
- AIR +4.1% (awarded a $305 mln Navy contract)
- AREC +3.7% (to delay 10-K filing)
- MRP +3.6% (files mixed securities shelf offering)
- NIO +3.5% (March deliveries)
- CAI +3.5% (finalizes Achieve 1 Study results reinforcing the superior sensitivity and specificity of Caris Detect)
- INFQ +2.9% (stock offering; also stock offering by selling shareholders)
- HHH +2.8% (reschedules shareholder meeting)
- XPEV +2.3% (March deliveries)
- USAU +2.1% (highlights upside potential beyond CK project feasibility baseline)
- RGTI +2% (announces Novera QPU sale)
- TMC +1.9% (files mixed securities shelf offering)
- ARX +1.9% (names new CFO)